PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-100.00%
Negative revenue growth while SMR.AX stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-100.00%
Negative gross profit growth while SMR.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
10.60%
EBIT growth of 10.60% while SMR.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
10.60%
Operating income growth of 10.60% while SMR.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
13.84%
Net income growth of 13.84% while SMR.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
23.33%
EPS growth under 50% of SMR.AX's 68.85%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.33%
Diluted EPS growth under 50% of SMR.AX's 68.85%. Michael Burry would worry about an eroding competitive position or excessive dilution.
16.66%
Share change of 16.66% while SMR.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
16.66%
Diluted share change of 16.66% while SMR.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-46.46%
Negative OCF growth while SMR.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-93.76%
Negative FCF growth while SMR.AX is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-100.00%
Negative 10Y revenue/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-25.54%
Negative 10Y OCF/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-25.54%
Negative 5Y OCF/share CAGR while SMR.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-25.54%
Negative 3Y OCF/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
26.15%
10Y net income/share CAGR of 26.15% while SMR.AX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
26.15%
Net income/share CAGR of 26.15% while SMR.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
26.15%
Positive short-term CAGR while SMR.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.28%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.64%
We cut SG&A while SMR.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.